CDISC, PointCross, Chiltern

Wednesday News Briefs

October 10, 2007

By info@clinpage.com

According to Gary Buehler, director of the FDA’s Office of Generic Drugs (OGD), pharmaceutical companies should be developing the capabilities to submit common technical document (CTD) applications electronically, or should utilize eCTD applications. Although submitting both new drug applications (NDAs)…